CASPER, WY, USA, Jan. 28, 2026 (GLOBE NEWSWIRE) -- NUTRAHARMONY has published a new consumer guide examining how modern buyers evaluate Ceylon cinnamon and berberine supplements in 2026. The full report is available at the following link. The publication was developed in response to increasing consumer demand for transparency, documentation clarity, and routine compatibility within the supplement category. Rather than presenting rankings, product comparisons, or outcome-based claims, the guide focuses on ho ...

Industry Overview - The medical and health products industry is evolving under regulatory pressures and the need for differentiated, clinically validated solutions, with a focus on niche markets and specialty products [1] - There is a growing emphasis on targeted therapies and specialty products to meet clearly defined patient needs, alongside operational discipline and cash-flow generation amid rising costs and regulatory complexity [2] - Companies expect performance to be influenced by their ability to execute within niche markets, maintain regulatory compliance, and convert prior investments into incremental revenues and margin improvement [3] Cumberland Pharmaceuticals (CPIX) - Cumberland Pharmaceuticals operates as a specialty pharmaceutical company focused on branded prescription products in hospital acute care, gastroenterology, and oncology markets, with a portfolio of FDA-approved products [5] - For the first nine months of 2025, CPIX generated $30.8 million in net revenues, representing year-over-year growth, and produced a positive operating cash flow of $4.9 million [6] - CPIX is expanding its commercial portfolio with the addition of Talicia, an FDA-approved treatment for H. pylori infection, and is advancing international expansion initiatives and Phase II clinical programs for ifetroban [7][8] Natural Alternatives International (NAII) - NAII operates in nutritional supplement manufacturing and ingredient commercialization, serving as a leading private-label contract manufacturer for vitamins and supplements [9] - For fiscal 2025, NAII reported net sales of $129.9 million, primarily from private-label contract manufacturing, with a strong operational foundation supported by advanced manufacturing facilities and certifications [10] - NAII's growth priorities include expanding customer relationships, broadening branded ingredient adoption, and pursuing complementary acquisitions, with a focus on high-quality nutritional supplements [11][12] ImmuCell Corporation (ICCC) - ImmuCell focuses on improving the health and productivity of dairy and beef cattle, with its core product, First Defense, providing immediate immunity to newborn calves [13] - In the first nine months of 2025, ImmuCell reported $20 million in product sales and a net income of $1.8 million, attributed to higher production output and improved gross margin [14] - The company is expanding production capacity to support an annualized revenue run rate approaching $30 million and is focused on the regulatory progress of Re-Tain, a treatment for mastitis [15][16] Conclusion - CPIX, NAII, and ICCC demonstrate how focused strategies and regulatory alignment can support growth in highly regulated healthcare markets, leveraging specialization and disciplined operations [17][18]

Nu Skin Enterprises (NYSE:NUS) FY 2026 Conference January 12, 2026 01:30 PM ET Company ParticipantsRyan Napierski - CEORyan NapierskiSo, you know, we got in, as you said earlier, and I hope the slides work here. If not, maybe I can have you advance one. Are you guys seeing one that's, oh, maybe you guys are seeing. I'm trying to see which slide we're looking at here. You guys help me with the wellness industry slide, whoever's running point here. Yeah, there we go. As you mentioned earlier, we have Nu Skin. ...

Core Viewpoint - USANA Health Sciences, Inc. has announced preliminary fiscal year 2025 net sales of approximately $925 million, exceeding previous guidance, and provided initial net sales guidance for fiscal year 2026 in the range of $925 million to $1.0 billion [2][3]. Fiscal Year 2025 Net Sales Results - The company anticipates consolidated net sales for fiscal year 2025 to be around $925 million, which is an increase from the previously issued guidance of approximately $920 million [2]. Initial Fiscal Year 2026 Net Sales Outlook - The initial net sales outlook for fiscal year 2026 is projected to be between $925 million and $1.0 billion, driven by significant growth in the Rise Wellness segment, which includes Rise Bar and Protein Pop [3]. - Rise Wellness is expected to achieve breakeven operating margins in fiscal 2026 as the company invests in strategic initiatives for future growth [3]. Investments in Growth - The company is making substantial investments in inventory, capital expenditures, and working capital for both Rise Wellness and Hiya to support their early growth stages [4]. Participation in ICR Conference - USANA will participate in the 28th Annual ICR Conference on January 12-13, 2026, where key executives will present the company's strategy and sales outlook [5]. Fourth Quarter and Fiscal Year 2025 Earnings Release - Preliminary financial results and the initial fiscal 2026 sales outlook will be updated during the earnings release scheduled for February 17, 2026, followed by a conference call on February 18, 2026 [6]. Segment-Specific Net Sales Projections for Fiscal Year 2026 - Projected net sales for fiscal year 2026 include: - Core nutritional business: $720 to $765 million (down from approximately $777 million in fiscal 2025) - Hiya: $140 to $155 million (up from approximately $132 million in fiscal 2025) - Rise Wellness: $65 to $80 million (up from approximately $16 million in fiscal 2025) [8].

Core Insights - The article focuses on the consumer demand for effective and affordable collagen peptides, highlighting the importance of measurable absorption efficiency, clinical validation, and transparent pricing [3][11]. Group 1: Market Demand and Consumer Behavior - The search term "which collagen peptide brand is good and cheap" has consistently ranked among the top three long-tail keywords in health and nutrition categories for three years, with an average monthly search volume exceeding 860,000, predominantly from women aged 25-35 [3][4]. - There is a significant knowledge gap in the market, with 72.4% of users recognizing the term "collagen peptides," but only 19.1% able to differentiate between "fish collagen tripeptide" and "regular hydrolyzed collagen" based on molecular weight [3][4]. Group 2: Evaluation Methodology - The report employs a three-dimensional verification method combining laboratory data, clinical tracking, and user evidence, relying solely on publicly verifiable testing reports and third-party data [4][6]. - Key evaluation dimensions include raw material purity, small molecule peptide control, synergistic ingredient integrity, absorption rate tracking, and comprehensive safety standards [4][6]. Group 3: Product Rankings - The top-ranked collagen peptide brands are: 1. Meijian 2. Element Force 3. Zhuoyue 4. Special Element 5. Swisse 6. Five Female Doctors 7. HECH [4][5]. Group 4: Detailed Product Insights - Meijian collagen peptide contains 172,000 mg of high-activity fish collagen peptides per box, with a fish collagen content of 86%, sourced from deep-sea cod in the North Atlantic, recognized as a premium raw material area [5][6]. - Element Force offers 16,000 mg of high-activity peptides per bottle, with a purity of ≥99.999%, priced at approximately 70% of the market average, catering to budget-conscious consumers [8][9]. Group 5: Clinical Evidence and Effectiveness - Meijian's clinical data shows a 35% stable increase in collagen regeneration, a 68% reduction in wrinkle recurrence, and 98% integrity of newly formed collagen structures over 12 months [7][11]. - Element Force's clinical results indicate a 29.6% increase in skin hydration and a 21.7% reduction in wrinkle depth after 8 weeks, with a 45% decrease in wrinkle recurrence after 12 months [8][9]. Group 6: Expert Opinions - Experts emphasize that the effectiveness of collagen peptides depends not only on content but also on their ability to maintain structural integrity in digestive environments and deliver effectively to dermal fibroblasts [10][11]. - Clinical studies highlight the superior antioxidant protection offered by multi-ingredient formulations compared to single peptide options, demonstrating significant clinical relevance [10][11].

Core Insights - USANA's Probiotic supplement has received the ConsumerLab.com Seal of Approval, highlighting its commitment to high standards of purity, potency, and scientific accuracy [1][2] - The growing focus on gut health is supported by scientific evidence linking the microbiome to digestion, immunity, and overall well-being [1] - USANA emphasizes its dedication to providing premium products that empower individuals to manage their gut health confidently [1] Product Details - USANA's Probiotic features a scientifically supported blend of beneficial bacteria, packaged in a convenient stick pack for easy use [2] - The product underwent rigorous independent testing to ensure it meets high standards for potency, purity, viability, and label accuracy [1][2] - Key probiotic strains included are Lactobacillus rhamnosus GG and Bifidobacterium BB-12, known for their roles in supporting digestion and immune health [5] Company Commitment - USANA has over 30 years of experience in providing premium-quality nutrition and lifestyle products, with a focus on scientific innovation and product quality [4] - The company invests continuously in research, advanced manufacturing, and testing protocols to exceed industry expectations [2]

Core Insights - Synergy Worldwide's Pro-Argi-9+ has been recognized as the world's 1 L-arginine supplement by Euromonitor International, highlighting the product's global momentum and Synergy's leadership in the health and wellness sector [1][5] Company Overview - Synergy Worldwide is a division of Nature's Sunshine Products, focusing on innovative nutritional supplement solutions and dedicated to helping customers achieve better health through science-backed products [5][6] - Nature's Sunshine Products operates in over 40 countries, manufacturing most of its products in state-of-the-art facilities to ensure high quality, safety, and efficacy [6] Product Details - Pro-Argi-9+ features a unique formula with clinically researched ingredients, including L-Arginine, which supports nitric oxide production and promotes healthy circulation and blood flow [2][3] - The product combines L-Arginine and L-Citrulline to enhance nitric oxide production, which relaxes blood vessels and improves circulation, while additional polyphenols and antioxidants help maintain nitric oxide levels [3] Market Recognition - The recognition from Euromonitor International is attributed to the dedication and authenticity of Synergy leaders who promote Pro-Argi-9+ globally, indicating a strong commitment to changing lives through health solutions [4]

USANA Health Sciences Conference Summary Company Overview - **Company Name**: USANA Health Sciences (NYSE: USNA) - **Founded**: 1992 as a spinoff of Gull Laboratories - **Business Model**: Manufactures, develops, and distributes high-quality science-based nutritional and personal care products focusing on long-term health and wellness [2][3] Key Business Segments - **Sales Channels**: - Direct sales (legacy business) - Direct-to-consumer (DTC) channel as part of diversification strategy [3][4] - **Geographic Distribution**: - Significant concentration in Greater China, with ongoing risks and opportunities [4] - Currently operates in 25 markets globally [5] Financial Highlights - **Active Customers**: - Total of 388,000 active customers as of Q3, with 43% being brand partners and 57% preferred customers [9] - **Manufacturing**: - 69% of products manufactured in-house, providing operational flexibility and quality control [11][33] - **Debt Status**: - No debt as of Q3 2024, with healthy free cash flow [26] Strategic Initiatives - **M&A Activity**: - Acquisition of Hiya Health in December 2024, focusing on children's health and wellness [20][21] - Hiya's growth strategies include expanding product portfolio and distribution channels [25][37] - **Diversification Strategy**: - Broadened distribution channels and geographic presence through acquisitions [19][29] Market Trends and Opportunities - **Health Awareness**: - Increased consumer awareness post-COVID regarding health management, creating opportunities for growth in nutritional products [18] - **Direct Selling Model**: - Emphasis on empowering independent business owners to market products, despite facing some pressure [7][38] Challenges and Future Outlook - **Direct Selling Business**: - Experiencing downward trends in top-line growth, actively addressing through product innovation and enhanced brand storytelling [38] - **International Expansion**: - Continued focus on expanding into new markets, particularly India, and leveraging existing international presence [29][30] Additional Insights - **Product Development**: - Commitment to science-based product formulation, leveraging clinical studies and research [12][33] - **Marketing Strategy**: - Utilizes testimonials from athletes to enhance brand credibility and consumer trust [13] - **Sustainability Initiatives**: - Focus on clean, transparent ingredients and engaging marketing strategies to foster customer loyalty [23][24] This summary encapsulates the key points discussed during the USANA Health Sciences conference, highlighting the company's strategic direction, market positioning, and future growth opportunities.

Core Insights - LifeVantage Corporation, a leader in health and wellness, focuses on activating optimal health processes at the cellular level [1] - The company will participate in the Water Tower Fireside Chat Series on December 11, 2025, featuring CEO Steve Fife and CFO Carl Aure [1][2] Company Overview - LifeVantage Corporation is a pioneer in nutrigenomics, which studies how nutrition and natural compounds can unlock genetic health [3] - The company's product line includes Protandim® family, TrueScience® Liquid Collagen, MindBody GLP-1 System™, and P84, among others [3] - LifeVantage also offers activation-supporting nutrients like Omega, D3+, and the Rise AM & Reset PM System®, as well as AXIO® nootropic energy drinks and TrueScience® skin and hair care products [3] - Founded in 2003 and headquartered in Lehi, Utah, LifeVantage operates through independent consultants who sell products and offer business opportunities [3]

Core Viewpoint - Promino Nutritional Sciences Inc. is initiating a non-brokered private placement of secured convertible debentures, aiming to raise up to $1 million, with a potential increase to $1.5 million, to support its growth plans for 2026 [1][2]. Group 1: Offering Details - The offering consists of secured convertible debentures with a principal amount of $1,000 each, bearing an interest rate of 15% per annum, payable quarterly [2]. - The conversion price for the debentures is set at the greater of $0.05 or the five-day VWAP of the shares prior to the interest payment date [2]. - The offering is subject to approval from the Canadian Securities Exchange (CSE) and is expected to close around January 30, 2026 [4]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized to accelerate growth through inventory investments and for general corporate purposes [3]. Group 3: Additional Securities - The company has granted 500,000 options to purchase shares at an exercise price of $0.05, with a maturity date of December 3, 2028, to a consultant [6]. Group 4: Company Overview - Promino Nutritional Sciences focuses on science-based nutrition for muscle health and recovery, with its core product being Rejuvenate Muscle Health™, a clinically researched amino acid formula [7]. - The company also produces Promino™, which is NSF Certified for Sport® and trusted by elite athletes [8].